Vaxcyte, Inc. (PCVX)

NASDAQ

$74,72

$+17,97

(+31,82%)

Regular Market

Vaxcyte, Inc. (PCVX) Live Price Chart

Last updated: ⁦2026-10-05 15:52:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Vaxcyte, Inc. (PCVX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $74,72, with a market capitalization of $8,40B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $39,87 to $107,34. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8,40B
Open	$87,21
Day's High	$121,06
Day's Low	$15,51
Previous Close	$56,48
Volume	8,70M
Average Volume	1,15M
P/E Ratio	--
52-Week High	$107,34
52-Week Low	$39,87
Dividend Yield	--
Earnings Date	--

Vaxcyte, Inc. (PCVX) Stock Price Today

Vaxcyte, Inc. (PCVX) is currently trading at $74,72 as of 2026-10-05 15:36:03, up 32,30% ($18,24) from the previous close of $56,48

During today's regular trading session, PCVX has traded between $15,51 and $121,06, with a trading volume of 8,70M shares. The current price is near the middle of today's range.

Vaxcyte, Inc. (PCVX) 7-Day Stock Price Change

Over the past seven days, Vaxcyte, Inc. (PCVX) moved from $56,90 to $74,72, representing a gain of 31,32% ($17,82).

The stock traded between $55,09 and $107,34 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 1,60 million shares, down versus the previous seven-day period, indicating lower trading activity.

PCVX 52-Week Price Position

Position in Range: 51,7%

52W Low$39,87

52W High$107,34

PCVX is currently trading at $74,72, placing it 51,7% of the way from its 52-week low of $39,87 to its 52-week high of $107,34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Vaxcyte, Inc. (PCVX)?

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Vaxcyte, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	507
Exchange	NASDAQ
Company Website	https://www.vaxcyte.com

How to Buy Vaxcyte, Inc. (PCVX) Stock on MEXC

Eligible investors can buy real shares of Vaxcyte, Inc. (PCVX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PCVX and Place Your Order

Open the RealStocks trading page and search for PCVX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Vaxcyte, Inc. (PCVX) stock price today?

Vaxcyte, Inc. (PCVX) is currently trading at $ 74,72, up 32,30% ($18,24) from the previous close of $ 56,48. Intraday prices update in real time during regular trading hours.

2.Is PCVX stock going up or down today?

As of 2026-10-05 15:36:03, PCVX is trading at $ 74,72, up 32,30% ($18,24) from its previous close of $ 56,48. The stock has traded between $ 15,51 and $ 121,06 during today’s regular session. Past price movements do not guarantee future results.

3.What is PCVX pre-market price?

As of 2026-10-05 15:36:03, PCVX is trading at $ 87,20 in pre-market trading, up 54,39% ($30,72) from the previous close of $ 56,48. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PCVX after-hours price?

As of 2026-10-05 15:36:03, PCVX is trading at $ 56,48 in after-hours trading, down 0,01% ($0,00) from the regular-session close of $ 56,48. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PCVX stock trading now?

PCVX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PCVX sit relative to its 52-week high and low?

Over the past 52 weeks, PCVX has traded between a low of $ 39,87 and a high of $ 107,34. At $ 74,72, the stock is positioned 51,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Vaxcyte, Inc. in?

Vaxcyte, Inc. (PCVX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Vaxcyte, Inc.'s market capitalization and where is it listed?

Vaxcyte, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8,40B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PCVX valued in terms of P/E ratio and EPS?

PCVX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7,15. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Vaxcyte, Inc. pay a dividend?

Vaxcyte, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.